Best Drug Discovery Software - Page 2

Leadscope Model Applier

Leadscope Model Applier is a powerful, easy-to-use software solution for computational toxicology, providing accurate toxicity predictions, expert review capabilities, and regulatory-ready reports in seconds. With numerous models developed under a research collaboration agreement with the FDA, Leadscope Model Applier enables robust, defendable, and transparent toxicology assessments that reduce or even eliminate the need for costly animal or in vitro studies.

Average Rating: 5.0/5.0

Total Reviews: 1

Open Drug Discovery Toolkit (ODDT)

Open Drug Discovery Toolkit (ODDT) is modular and comprehensive toolkit for use in cheminformatics, molecular modeling etc. ODDT is written in Python, and make extensive use of Numpy/Scipy

Average Rating: 4.5/5.0

Total Reviews: 1

PEPID PDC

PEPID PDC gives healthcare professionals fast access to authoritative drug information, a comprehensive drug interactions checker, and a complete toxicology reference for safer, more effective care at the patient's bedside.

Average Rating: 3.0/5.0

Total Reviews: 1

Schrodinger

Data sharing and collaborative drug design across the entire discovery team in real time.

Average Rating: 5.0/5.0

Total Reviews: 1

Thermo Scientific Nautilus LIMS

Nautilus LIMS for Dynamic Discovery and R&D Environments is a highly flexible, easily configurable system that increases workflow efficiency, throughput and data reliability while simplifying administration, sample traceability and regulatory compliance.

Average Rating: 4.5/5.0

Total Reviews: 1

A-Alpha Bio

Synthetic biotechnology and ML to accelerate drug development, allowing researchers to discover, optimize, and characterize drugs more efficiently.

Absci

Absci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the therapeutic potential of proteins

Advera Health

Advera Health is a healthcare informatics company that uses data-mining and analytics for analysis of drug evidence.

adWATCH

adWATCH - AE helps pharmaceutical organizations manage and report adverse events that occur during clinical trials.

Agrematch

Agrematch is an innovative company specializing in the discovery and development of novel crop protection solutions. By leveraging advanced artificial intelligence and machine learning technologies, Agrematch accelerates the identification of effective agrochemicals, addressing the pressing need for sustainable and efficient agricultural practices. Key Features and Functionality: - AI-Driven Discovery: Utilizes proprietary AI algorithms to rapidly identify potential agrochemical candidates, significantly reducing the time and cost associated with traditional discovery methods. - Comprehensive Data Analysis: Integrates vast datasets, including chemical, biological, and environmental information, to predict the efficacy and safety of new compounds. - Sustainable Solutions: Focuses on developing environmentally friendly products that meet regulatory standards and promote sustainable agriculture. - Collaborative Platform: Offers partnerships with agricultural companies, providing access to cutting-edge technology and expertise in agrochemical development. Primary Value and User Solutions: Agrematch addresses the critical challenge of developing new crop protection products in a time-efficient and cost-effective manner. By harnessing AI and machine learning, the company enables the rapid discovery of novel agrochemicals, helping farmers combat pests and diseases while minimizing environmental impact. This approach not only enhances crop yields and food security but also supports the global shift towards sustainable agricultural practices.

AIDDISON

Aitia

Aitia

Algen Biotechnologies

Algen Biotechnologies is a pioneering therapeutics company that integrates advanced CRISPR gene-modulation with artificial intelligence to revolutionize drug discovery. Originating from Nobel Laureate Jennifer Doudna's lab at UC Berkeley, Algen focuses on developing innovative medicines targeting diseases with significant unmet needs, such as cancer and chronic inflammatory conditions. By reverse-engineering disease trajectories, Algen aims to identify and modulate disease-driving RNA pathways, offering precise and effective therapeutic solutions. Key Features and Functionality: - AlgenCRISPR Gene-Modulation System: A proprietary, next-generation CRISPR technology that provides robust, fine-tuned, and precise gene modulation. This system enables the deconvolution of complex biological processes, facilitating the identification of novel therapeutic targets. - AlgenBrain Platform: An AI-driven foundation model that analyzes billions of real-time, dynamic gene expression changes occurring throughout disease progression. By mapping causal links between gene regulation and disease outcomes, AlgenBrain predicts RNA signaling networks, accelerating the discovery of effective treatments. Primary Value and User Solutions: Algen Biotechnologies addresses the critical challenge of developing therapies for complex diseases with high unmet needs. By combining cutting-edge CRISPR technology with AI-driven analytics, Algen enhances the precision and speed of identifying disease-driving mechanisms. This integrated approach not only improves the translational accuracy of potential therapies but also increases the probability of clinical success, ultimately leading to more effective treatments for patients. Through strategic partnerships, such as the multi-target collaboration with AstraZeneca, Algen is poised to transform the future of medicine by delivering innovative, human-centric therapeutic solutions.

American Gene Technologies

American Gene Technologies (AGT) practices the art and science of genetic medicine. AGTrobust programs of discovery and drug development also include efforts on research and development of genetic medicines for treating Parkinsondisease and familial dysautonomia a rare, inherited orphan disease that is characterized by early onset blindness and other neurological problems. As priority programs move toward clinical testing, and as AGT continues to grow, these and other areas of investigation will expand and refine the genetic medicine strategies while advancing toward the clinic alongside other focus areas.